Shattuck Labs (STTK) Cash from Investing Activities (2019 - 2026)

Shattuck Labs' (STTK) quarterly Cash from Investing Activities came in at $23.8 million in Q1 2026, up 52.87% year-on-year from $15.6 million in Q1 2025, and up 19.24% on a QoQ basis from $20.0 million in Q4 2025.

Shattuck Labs (STTK) Cash from Investing Activities (2019 - 2026) Analysis & Trends

Shattuck Labs (STTK) has 8 years of Cash from Investing Activities data on file, last reported at $23.8 million in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 52.87% year-over-year to $23.8 million in Q1 2026; TTM through Mar 2026 was $361000.0, a 99.11% decrease from a year earlier, with the FY2025 full-year figure at -$7.9 million, up 7.33% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at $23.8 million, up from $20.0 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for STTK reached as high as $55.9 million in Q4 2023 and fell as low as -$43.5 million in Q3 2025.
  • Historically, Cash from Investing Activities has averaged $10.5 million across 5 years, with a median of $17.8 million in 2025.
  • Across the five-year window, Cash from Investing Activities surged 611.71% in 2023 and slumped 5196.83% in 2025, its largest moves.
  • Year by year, Cash from Investing Activities stood at $31.5 million in 2022, then surged by 77.52% to $55.9 million in 2023, then plunged by 44.5% to $31.0 million in 2024, then slumped by 35.48% to $20.0 million in 2025, then climbed by 19.24% to $23.8 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were $23.8 million in Q1 2026, $20.0 million in Q4 2025, and -$43.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -45.51 Mn
4 NuCana 279.75 Bn 279.75 Bn - 178,242.27
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 172.62 Mn
10 Shattuck Labs 795.74 Mn 795.74 Mn - 23.85 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 23.85 Mn
Mar 31, 2026 23.85 Mn
Dec 31, 2025 20.00 Mn
Dec 31, 2025 20.00 Mn
Sep 30, 2025 -43.49 Mn
Sep 30, 2025 -43.49 Mn
Mar 31, 2025 15.60 Mn
Mar 31, 2025 15.60 Mn
Dec 31, 2024 31.00 Mn
Dec 31, 2024 31.00 Mn
Sep 30, 2024 -821,000.00
Sep 30, 2024 -821,000.00
Jun 30, 2024 -5.41 Mn
Jun 30, 2024 -5.41 Mn
Mar 31, 2024 -33.28 Mn
Mar 31, 2024 -33.28 Mn
Dec 31, 2023 55.85 Mn
Dec 31, 2023 55.85 Mn
Sep 30, 2023 -14.55 Mn
Sep 30, 2023 -14.55 Mn